National Drug Shortages
New Shortages by Year
January 2001 to December 2023
Note: Each column represents the number of new shortages identified during that year.
University of Utah Drug Information Service
Contact: [email protected], @foxerinr for more information.
National Drug Shortages
New Shortages by Year
January 2001 to December 2023, % Injectable
Note: Each column represents the number of new shortages identified during that year.
University of Utah Drug Information Service
Contact: [email protected], @foxerinr for more information.
National Drug Shortages
Active Shortages by Quarter – 10 Year Trend
Note: Each point represents the number of active shortages at the end of each quarter.
University of Utah Drug Information Service
Contact: [email protected], @foxerinr for more information.
National Drug Shortages
Active Shortages Top 5 Drug Classes
University of Utah Drug Information Service
Contact: [email protected], @foxerinr for more information.
National Drug Shortages
Common Drug Classes in Short Supply – 5 Year Trend
University of Utah Drug Information Service
Contact: [email protected], @foxerinr for more information.
National Drug Shortages
Reasons for Shortages as Reported by Manufacturers
During UUDIS Investigation
University of Utah Drug Information Service
Contact: [email protected], @foxerinr for more information.
Summary
- Ongoing and active shortages are the highest in a decade and have been over 300 for a year.
- Recent survey data show shortages impact patient care.
- Shortages of chemotherapy drugs driven by poor manufacturing quality resulted in rationing of care
- Workload required to manage shortages, including work to change pharmacy automation and electronic health records, adds to the challenges of pharmacy staff shortages.
Selected Links of Interest
- Federal Policies to Address Persistent Generic Drug Shortages
- ASHP Drug Shortage Survey Report
- Energy & Commerce Health Subcommittee (hearing)
- Senate Finance Committee (hearing)
- Senate Committee on Homeland Security & Governmental Affairs (hearing and report)
- Building Resilience Into US Prescription Drug Supply Chains
- National Academies of Science, Engineering, and Medicine to examine the security of America’s medical product supply chain
- Improving the Quality and Resilience of the United States Healthcare Supply Chain
- National Strategy for a Resilient Public Health Supply Chain
- Essential Prescription Drugs Supply Chain and Manufacturing Resilience Assessment